Related by context. All words. (Click for frequent words.) 68 Cryoablation System 63 Phase IIIb clinical 62 Raptiva ® 62 Cellegesic 62 Evoltra TM 62 treat chronic sinusitis 62 HYVISC R 61 Iluvien ® 61 Icatibant 61 BioSTAR R 60 Soliris eculizumab 60 Cimzia TM 60 terlipressin 59 Sanvar R 59 Voraxaze 59 antiarrhythmic drug 59 Phase IIIb study 59 REPEL CV 59 PFO closure 59 SYCREST 59 rThrombin 59 COMFORT II 59 Dupuytren Contracture 59 Modrenal R 59 carotid stents 59 OMAPRO ™ 59 Vimpat ® lacosamide 59 OvaRex ® MAb 59 hoFH 59 Angiox 59 Phase IIb clinical trials 59 GTC recombinant human 59 Carticel 59 Edwards SAPIEN valve 59 Raptiva R 59 PrevOnco ™ 59 refractory angina 59 Soliris TM eculizumab 58 lucinactant 58 endovascular aneurysm repair EVAR 58 severe hypercholesterolemia 58 Rescula 58 symptomatic uterine fibroids 58 Zenapax 58 MIST II 58 chronic hyperuricaemia 58 Increlex TM 58 Deferiprone 58 novel oral anticoagulant 58 Voraxaze ™ 58 VNS Therapy TM 58 Personalized Immunotherapy 58 drug ISA# 58 Firazyr 58 Neuromodulation System 58 Advagraf 58 SomatoKine 58 endovascular stent grafts 58 UPLYSO 58 Yentreve 58 hypoparathyroidism 58 overactive bladder syndrome 58 eSVS MESH 58 pain palliation 58 Plenaxis TM 58 Dacogen injection 58 Esbriet pirfenidone 58 MelaFind ® 58 ecallantide 58 PrevOnco 58 Somatuline R Autogel R 58 Humanitarian Device Exemption 58 TAXUS TM 58 PROMUS TM 58 EGRIFTA TM 58 catheter occlusion 58 acute HAE attacks 58 Embosphere Microspheres 58 SurgiFrost 58 Levulan PDT 58 pediatric Crohn disease 58 Acute Myocardial Infarction AMI 58 dirucotide 57 Vascular Wrap TM 57 Certican 57 DEEP AF 57 Orphan Status 57 BEXXAR 57 Investigational Device Exemption 57 Augment Injectable 57 CORTOSS 57 Navelbine ® 57 peripheral vascular stent 57 lomitapide 57 Européenne Mark 57 Phase #b/#a clinical 57 lupus nephritis 57 generation purine nucleoside 57 ATryn R 57 relapsing remitting MS RRMS 57 SANVAR 57 OsseoFix 57 phase IIb trial 57 Premarket Approval Application 57 liver resection surgeries 57 Veregen TM 57 STEDESA 57 Alvesco R 57 acetonide FA 57 HepaSphere 57 treat atrial flutter 57 CoreValve System 57 endovascular stent graft 57 Evoltra ® 57 Troxatyl 57 Combidex 57 Plenaxis R 57 CE Marked 57 RH1 57 Pivotal Clinical Trial 57 calcineurin inhibitor 57 Ciclesonide 57 vapreotide acetate 57 carotid stent 57 alvimopan 57 LEUKINE 57 thromboembolic disease 57 Drug Eluting Stent System 57 relapsed leukemia 57 miconazole Lauriad R 57 chronic ITP patients 57 percutaneous aortic valve 57 oxymorphone ER 57 MicroThermX Microwave Ablation System 57 vernakalant hydrochloride 57 Aviptadil 57 TELINTRA 57 renal anemia 57 FOLOTYN ® 57 Fast Track designations 57 oropharyngeal candidiasis 57 Arzerra ofatumumab 57 NeuroStar TMS Therapy 57 Ablatherm R 57 hereditary deficiency 57 MAGE A3 ASCI 57 Dementia Related Psychosis 57 Cotavance 57 CINTREDEKIN BESUDOTOX 57 CryoSeal FS System 57 prokinetic agent 57 ONCASPAR 57 HoFH 57 Prestara 57 elective PCI 57 ATryn ® 57 Silodosin 57 TRISENOX R 57 acyclovir Lauriad ® 57 Fodosine 57 thalidomide Thalomid 57 Angiox R 57 CTO recanalization 57 benign prostatic hypertrophy BPH 56 Junovan 56 Augment Bone Graft 56 Powerlink System 56 neurogenic bladder 56 received CE Marking 56 thrombolytic agent 56 mild vasodilator 56 RhuDex ® 56 CytoSorb TM 56 Alzhemed TM 56 Premarket Approval 56 YONDELIS 56 Oracea ® 56 Octreolin 56 Zytiga 56 Orphan Drug Status 56 aortic stent grafts 56 GED aPC 56 Fibrillex TM 56 arterial thrombosis 56 SilverHawk Plaque Excision System 56 TAXUS Element Stent System 56 Orphan Drug designations 56 tuberous sclerosis TS 56 symptomatic paroxysmal AF 56 Pivotal Trial 56 Somatuline Autogel 56 Dyloject TM 56 R sorafenib tablets 56 acyclovir Lauriad R 56 alpha interferons 56 markets HP Acthar 56 XIAFLEX ® 56 orthoPACE ™ 56 delivers fluocinolone acetonide FA 56 PROVENGE ® 56 Valtropin 56 Fx #A 56 faropenem medoxomil 56 ORTHOVISC mini 56 Certolizumab pegol 56 octreotide implant 56 REMICADE ® 56 Increlex 56 Iluvien TM 56 BioSTAR ® 56 IV Busulfex 56 refractory APL 56 Heartmate 56 ENTEREG ® 56 LUCASSIN 56 LEVADEX ™ 56 CryoSeal 56 vertebral compression fractures 56 oxypurinol 56 Ozurdex 56 oropharyngeal candidiasis OPC 56 biliary stent 56 Cardima Surgical Ablation System 56 Surgical Ablation System 56 PROMUS Element 56 TAXUS Element Paclitaxel Eluting 56 FavId 56 lorvotuzumab mertansine 56 Clolar ® 56 Civacir 56 Fortigel 56 Hepatocellular Carcinoma HCC 56 Evoltra R 56 ablation procedures 56 Omigard 56 drug eluting stent DES 56 pseudobulbar affect PBA 56 AA amyloidosis 56 herpetic keratitis 55 Rilonacept 55 RX ACCULINK 55 PDX pralatrexate 55 AMEVIVE 55 CRMD# 55 Pafuramidine 55 vidofludimus 55 TRISENOX ® 55 Loramyc ® 55 AERx iDMS 55 PD2i Analyzer 55 Visian Toric ICL 55 phase IIb clinical 55 Sanctura XR 55 ThromCat 55 Angiox ® 55 Zenpep 55 postherpetic neuralgia PHN 55 Linjeta TM 55 Keppra ® levetiracetam 55 refractory metastatic colorectal cancer 55 peritumoral brain edema 55 Uvidem 55 TM Drug Eluting 55 Zelrix 55 Kepivance 55 Efficacy Results 55 SILENOR 55 Anturol TM 55 diabetic neuropathic pain 55 FACTIVE R gemifloxacin 55 Degarelix 55 Corlux 55 tafamidis 55 Application MAA 55 NEBIDO 55 systemic immunosuppressive drugs 55 CIP TRAMADOL ER 55 secondary hyperparathyroidism 55 Pyridorin 55 ularitide 55 BLA submission 55 XIENCE V stent 55 gastrointestinal disorders ATI 55 Tarceva TM 55 HDL Selective Delipidation 55 Orphan Drug status 55 Nabi HB Intravenous 55 sNDAs 55 Fludara ® 55 Loramyc R 55 Syndrome LEMS 55 Marketing Authorisation Application 55 SinuNase TM 55 EsophyX 55 SEPET TM 55 Zirgan 55 gepirone ER 55 EVLT 55 AzaSite Xtra 55 Acute Radiation Syndrome ARS 55 BrachySil ™ 55 refractory chronic lymphocytic 55 Manja Bouman CEO 55 Retacrit 55 antiplatelet medications 55 Trobalt 55 Albugon 55 EchoCRT 55 Rhucin ® recombinant 55 GEM OS1 55 kidney urologic 55 Evicel 55 OMNARIS Nasal Spray 55 refractory epilepsy 55 Oracea TM 55 RELISTOR ® 55 Menaflex device 55 induced macular edema 55 PMA submission 55 minimally invasive interventional 55 oral methylnaltrexone 55 MONOVISC 55 EVICEL 55 radiotherapeutic 55 FDA Approvable Letter 55 TransMID TM 55 blood clot dissolver 55 Initiates Enrollment 55 Pegloticase 55 sumatriptan DosePro 55 BrachySil TM 55 Iluvien 55 BRILINTA 55 SPRYCEL ® 55 oral ridaforolimus 55 Phase #b/#a trial 55 EVIZON TM 55 Pirfenidone 55 esophageal candidiasis 55 saphenous vein graft 55 nasal calcitonin product 55 Sutent sunitinib 55 InterStim Therapy 55 ALN PCS 55 Kit CD# positive 55 confirmatory Phase III 55 cinacalcet HCl 55 allogeneic bone marrow 55 mertansine 55 R bendamustine hydrochloride 55 Neovasc Reducer 55 nosocomial pneumonia 55 minimally invasive Percutaneous Myocardial 55 candidate TNFerade biologic 55 topical NSAID 55 TEMODAL 55 SUPPRELIN LA 55 Orphan Drug designation 55 MyVax R 55 ENRICH trial 55 SUPPRELIN R LA 55 BioDisc 55 intravenous acetaminophen 55 adjunctively 55 severe gastroparesis 55 recurrent glioblastoma multiforme 55 MelaFind R 55 Ecallantide 55 Humira adalimumab 55 Stedesa 55 orphan designation 55 Sonolith i move 54 relapsed refractory multiple myeloma 54 Monovisc 54 HepeX B 54 post herpetic neuralgia PHN 54 Cancidas 54 ORENCIA R 54 BLA filing 54 Endoscopic Ablation System 54 Serdolect ® 54 painful diabetic neuropathy 54 Cook Zenith TX2 54 urethral bulking agent 54 LOVENOX R 54 tramiprosate ALZHEMED TM 54 rilonacept 54 PREOS 54 NICOSAN TM 54 MOZOBIL 54 Marketing Authorization Applications 54 Investigational Device Exemption IDE 54 EOquin 54 Vascugel 54 ELIQUIS 54 JAK inhibitor 54 XIENCE V Everolimus Eluting 54 QuadraSphere 54 PROCRIT R 54 European Sepsis Trial 54 pharmacologic stress 54 MOVIPREP R 54 MyVax ® 54 Neo Bladder Augment 54 personalized immunotherapy 54 ruxolitinib 54 Firazyr ® 54 diarrhea predominant irritable 54 ClosureFAST catheter 54 thoracic aortic aneurysms 54 ARIXTRA 54 HepaGam B 54 EGRIFTA ™ 54 hereditary antithrombin deficiency 54 Phase #b/#a 54 Artelon ® 54 Abbokinase 54 tramiprosate Alzhemed TM 54 Phenoptin 54 oral antiplatelet agent 54 Gleevec imatinib mesylate 54 spinal compression fractures 54 Thalomid ® 54 EP #R 54 Rectogesic 54 Achieves Primary Endpoint 54 OZURDEX ® 54 methylnaltrexone bromide 54 Ceflatonin 54 Panzem R 54 ranibizumab Lucentis 54 DITPA 54 #L Ozone Sterilizer 54 Orapred ODT 54 osteoarthritis rheumatoid arthritis 54 acute decompensated heart 54 L BLP# 54 adult chronic ITP 54 StomaphyX 54 multicenter clinical trials 54 Proquin XR 54 Initiates Clinical 54 ONGLYZA ™ 54 DYSPORT TM 54 symptomatic BPH 54 diabetic peripheral neuropathy 54 hypervascular tumors 54 Cerashield 54 SIR Spheres microspheres 54 MPS IVA 54 HuMax CD4 54 Zemiva TM 54 calcineurin inhibitors 54 BENLYSTA ® 54 Zavesca R 54 rFVIIa 54 Premarket Approval PMA 54 Pivotal Study 54 recurrent NSCLC 54 Thrombectomy System 54 PREOS R 54 Frova ® 54 INFUSE Bone Graft 54 single injection viscosupplement 54 Onalta ™ 54 TRANSDUR Sufentanil 54 Alemtuzumab 54 orphan medicinal product 54 registrational 54 CAELYX 54 Acute Radiation Syndrome 54 gynecologic procedures 54 interferon gamma 1b 54 NP2 Enkephalin 54 successfully commercialize Iluvien 54 PEGINTRON TM 54 Zenvia ™ 54 Zavesca ® 54 Perforomist ™ Inhalation Solution 54 POSIDUR TM 54 hyperplasia BPH 54 IPLEX 54 AVONEX PEN 54 Granted Orphan Drug 54 MYLOTARG 54 Ventavis 54 coronary intervention 54 Entereg R 54 Spectranetics laser 54 PD2i Cardiac Analyzer 54 subependymal giant cell 54 P#X# antagonist 54 Arcalyst 54 atrial arrhythmias 54 Aryplase 54 Receives Orphan Drug Designation 54 tiapamil 54 VALSTAR TM 54 IL# PE#QQR 54 SIR Spheres 54 diabetic macular edema 54 STARFlex R 54 either acutely decompensated 54 vitreoretinal disorders 54 Marketing Authorization Application 54 Embolic Protection Device 54 Enzyme Replacement Therapy 54 Preos 54 QVAR 54 BR.# 54 Adhesion Barrier 54 biliary stents 54 Teysuno 54 ExAblate R 54 Rhucin R 54 Hedgehog Pathway Inhibitor 54 midstage trials 54 Vectibix panitumumab 54 Accelerated Approval 54 squalamine 54 romiplostim 54 XIENCE 54 Cethrin 54 Targretin capsules 54 Zavesca r 54 PCA3 assay 54 VALSTAR 54 miconazole Lauriad ® 54 ADAGIO study 54 #D#C# 54 CardioPass TM 54 Adentri 54 Xyrem ® 54 WallFlex Biliary RX 54 bifurcation stent 54 polidocanol 54 corticotropin injection 54 Biliary System 54 Isolagen Process 54 LVAS 54 Vicinium TM 54 metastatic malignant 54 dermaPACE TM 54 Freezor 54 functional mitral regurgitation 54 adalimumab Humira 54 NYHA Class II 54 transcatheter closure 54 FDA Investigational Device 54 IONSYS TM 54 pharmacologic stress agent 54 methylnaltrexone 54 lanreotide 54 VAPRISOL 54 punctal plug delivery 54 Cleviprex TM clevidipine 54 Fast Track designation 54 Testim R 54 myoblast therapy 54 omacetaxine mepesuccinate 54 Kamada AAT 54 Archexin 54 UCB Cimzia 54 LymphoStat B TM 54 CLIA waiver 54 Gel repository corticotropin injection 54 Cinryze ™ 54 ONTAK 54 Liprostin 54 coronary vascular 54 Pivotal Phase III 54 DepoBupivacaine TM 54 dexanabinol 54 hormone agonist 54 drug eluting coronary stent 54 refractory Hodgkin lymphoma 54 MicroThermX 53 Cellulaze 53 SUTENT ® 53 pulmonary arterial hypertension 53 Activase 53 TYZEKA 53 PERLANE 53 PerClot 53 immune thrombocytopenic purpura ITP 53 AZILECT ® 53 BioMatrix TM 53 Market Approval PMA 53 Insegia 53 lenalidomide Revlimid R 53 GEM #S 53 lexidronam injection 53 Xcytrin R 53 MAb therapy 53 MAA submission 53 ULTRASE 53 aripiprazole Abilify 53 multiple myeloma MM 53 Zemplar 53 anticlotting drugs 53 Cypher Sirolimus 53 OMNARIS HFA 53 post operative ileus 53 Vitrasert R 53 GEM OS2 53 acadesine 53 SNT MC# 53 RSR# 53 Somatuline ® Depot 53 panitumumab Vectibix 53 Argatroban 53 Cardica Microcutter XPRESS 53 Myfortic 53 biologic therapy 53 Embolic Protection System 53 Cinquil 53 Fully Covered Stent 53 Urocortin 2 53 Factor VIIa 53 vertebral augmentation 53 Ambrisentan 53 TheraCIM h R3 53 Rheos System 53 KIACTA ™ 53 Tramiprosate ALZHEMED TM 53 Onco TCS 53 Soft Tissue Sarcoma 53 WATCHMAN device 53 torsemide ER 53 Urocidin 53 Orencia abatacept 53 apricitabine 53 chronic myocardial ischemia 53 ADVEXIN therapy 53 Frozen Shoulder Syndrome 53 opioid induced bowel dysfunction 53 erlotinib Tarceva ® 53 Periowave TM Photodisinfection System 53 DNAwithPap TM Test 53 Oxycyte ® 53 endoluminal stent graft 53 ATL# [001] 53 Cimzia R 53 Gamunex C 53 ATPace TM 53 Surfaxin LS 53 Onko Sure TM 53 ADVEXIN clinical 53 LibiGel ® 53 PREVU * POC 53 JOULFERON 53 Li Fraumeni Syndrome 53 NEBIDO R 53 clinical pharmacology studies 53 ZYFLO R 53 AzaSite Plus 53 PANVAC VF 53 registrational studies 53 chronic angina 53 rheumatoid arthritis osteoarthritis ankylosing 53 Thrombin 53 XIAFLEX ™ 53 MULTAQ 53 thetreatment 53 Liprotamase 53 Phase Ib IIa 53 opioid induced constipation OIC 53 Phase III multicenter 53 targeted radiotherapeutic 53 asymptomatic hyperuricemia 53 collagen meniscus implant 53 ALVESCO HFA 53 VTE prophylaxis 53 relapsing multiple sclerosis 53 oncology indications 53 intravenous formulations 53 mechanical thrombectomy 53 phase IIa clinical 53 immunomodulatory therapy 53 Stedivaze 53 medically refractory 53 ZoMaxx 53 phase III isavuconazole 53 5 lipoxygenase inhibitor 53 investigational 53 Augment ™ 53 treat enlarged prostate 53 pancreatic neuroendocrine tumors 53 TORISEL 53 Glufast 53 hormone LHRH antagonist 53 intravenous iclaprim 53 metastatic neuroendocrine tumors 53 Octreotide 53 PI3K/Akt pathway inhibitor 53 Neulasta R 53 hypoxia activated prodrug 53 Junovan TM 53 dextofisopam 53 SinuNase 53 Vascular Closure Device 53 LymphoStat B belimumab 53 RhuDex 53 DEFINITY ® 53 silodosin 53 Transcatheter aortic valve implantation 53 NEUPOGEN 53 heterozygous FH 53 coronary artery stents 53 RSD# oral 53 NanoCrystal technology 53 buccal spray 53 Lambert Eaton Myasthenic 53 REVLIMID lenalidomide 53 gastrointestinal stromal tumors GIST 53 PIX# trial 53 ILUVIEN ® 53 external counterpulsation systems 53 Behcet uveitis 53 Tectin TM 53 AutoloGel tm System 53 Diabetic Macular Edema DME 53 Medidur TM FA 53 treating abdominal aortic 53 Tredaptive 53 Biologic License Application BLA 53 Alair System 53 Peyronie Disease 53 PD LID 53 INVANZ 53 Ceflatonin R 53 Cx# [002] 53 Nexavar sorafenib 53 Gelclair 53 Sebivo 53 TriActiv System 53 pediatric malignancies 53 intravenous AAT 53 Pemetrexed 53 Phase IIb III 53 voclosporin 53 subcutaneous formulation 53 lung liver pancreas 53 diabetic macular edema DME 53 cancer neuroendocrine tumor 53 myelodysplastic myeloproliferative diseases 53 paclitaxel eluting 53 budesonide foam 53 angioplasty stenting 53 EECP R 53 ATryn ® GTC recombinant 53 initiate Phase 1b 53 immunosuppressive therapies 53 orthoPACE 53 NUEDEXTA ™ 53 Sestamibi 53 pancreatic insufficiency 53 IBV Valve System 53 Fast Track Designation 53 neovascular diseases 53 severe hypersensitivity reactions 53 Tibolone 53 vascular insufficiency 53 XIENCE PRIME 53 VALOR trial 53 Golimumab 53 carcinoid syndrome 53 Vacuum Assisted Closure 53 Microcutter 53 invasive candidiasis 53 malignant pleural mesothelioma 53 OMAPRO 53 Topical Interferon Alpha 2b 53 CoStar stent 53 Neulasta ® 53 TRIOLEX HE# APOPTONE HE# 53 FIRMAGON 53 Vantas 53 ARIKACE ™ 53 novel emulsion formulation 53 HuMax TAC 53 Carotid endarterectomy 53 treat benign prostatic 53 Durezol TM 53 IoGen 53 SJIA 53 chronic thromboembolic pulmonary 53 deferiprone 53 fluvoxamine maleate 53 received CE Conformite 53 Velcade bortezomib 53 reslizumab 53 Completes Patient Enrollment 53 faropenem 53 thrombolytics 53 cardioverter defibrillator 53 Omapro 53 Edurant 53 Plicera 53 factor VIIa 53 Coronary Stent System 53 anterior lumbar interbody fusion 53 Asclera 53 Allovectin 7 R 53 Methylnaltrexone 53 ISTODAX 53 Phase IIa clinical trials 53 BrachySil 53 non alcoholic steatohepatitis 53 percutaneous valve 53 varicose vein treatment 53 TAXUS Stents 53 TissuGlu 53 Phase 2b clinical 53 Tamibarotene 53 R lenalidomide 53 Eluting Coronary Stent System 53 depo subQ provera 53 sNDA submission 53 Selective Electrochemical Tumor Ablation 53 non metastatic osteosarcoma 53 Levoleucovorin 53 NeoDisc 52 Aerosurf 52 novel histone deacetylase 52 Submits Response 52 Exocrine Pancreatic Insufficiency 52 autoimmune indications 52 AA Amyloidosis 52 Dalbavancin 52 Cintredekin Besudotox 52 NAVISTAR R 52 Phase 2b clinical trials 52 RSD# iv 52 PROMUS Element Everolimus Eluting 52 opioid bowel dysfunction 52 BLP# Liposome Vaccine 52 EFAPROXYN 52 intravenous formulation 52 ProUroScan 52 TH# [003] 52 PROCRIT ® 52 intravenous RSD# 52 phase IIb study 52 transplantation HCT 52 Phase IIB 52 RECOTHROM R 52 Xanafide 52 metformin accumulation 52 somatostatin analogues 52 oral dual endothelin 52 LEP ETU 52 balsalazide tablet 52 novel VDA molecule 52 Bucindolol 52 paliperidone palmitate 52 Artificial Disc 52 superficial bladder cancer 52 XIAFLEX TM 52 Diamondback #deg 52 Daclizumab 52 Excellagen 52 rituximab refractory follicular 52 Thelin tm 52 metastatic liver 52 Amrubicin 52 ZOLINZA 52 Destination Therapy 52 SHPT 52 please visit http:/www.sunesis.com 52 photodynamic therapy PDT 52 Azathioprine 52 liver resection 52 rheumatoid arthritis Crohn disease 52 DC Bead 52 trastuzumab DM1 T DM1 52 visilizumab 52 InterfeRx 52 ABLAVAR ® 52 StemEx 52 KYNAPID 52 anthracycline taxane 52 Cethrin R 52 Campath ® 52 sorafenib tablets 52 docetaxel Taxotere ® 52 Bicifadine 52 forodesine 52 sunitinib Sutent 52 investigational humanized monoclonal antibody 52 pulmonary arterial hypertension PAH 52 advanced metastatic renal 52 DDP# 52 tolevamer 52 MYCAMINE 52 Diabetic Macular Edema 52 Reports Preclinical Data 52 Troxatyl TM 52 NUEDEXTA 52 Powerlink ® 52 Medidur 52 Xyfid 52 Lung Flute 52 Temodar ® 52 alogliptin 52 Urocidin TM 52 randomized Phase IIb 52 antibody MAb 52 prostate TURP 52 oral anticoagulant 52 Neo Urinary Conduit 52 Telavancin 52 retinal specialists 52 vismodegib 52 Ventavis ® 52 clofarabine 52 Clofarabine 52 inhaled formulation 52 thrombolytic agents 52 embolotherapy 52 hereditary angioedema 52 Phase IIa trial 52 Reloxin ® 52 Angiomax ® 52 bardoxolone 52 juvenile idiopathic arthritis 52 investigational therapies 52 HQK 52 multicenter Phase III 52 Kuvan R 52 monoclonal antibody therapeutics 52 dirucotide MBP# 52 Friedreich Ataxia FRDA 52 midstage clinical trials 52 Gliadel Wafer 52 ATL# [002] 52 SIMPONI TM 52 6R BH4 52 therapeutic modalities 52 CytoFab 52 Oxiplex 52 OvaRex R 52 histamine dihydrochloride 52 bioabsorbable stent 52 Ostarine TM 52 MRgFUS 52 PEGylated interferon 52 Generx TM 52 Phase #/#a trial 52 Firdapse 52 mitoxantrone concentrate 52 Multiferon 52 voiding dysfunctions 52 Zerenex 52 LPM TM 52 Convivia TM 52 Genasense ® 52 malignant ascites 52 Levulan ® PDT 52 Actemra tocilizumab 52 HepaGam B TM 52 EXJADE 52 MIS# 52 BCR ABL inhibitors 52 Known hypersensitivity 52 riociguat 52 Mozobil 52 Fast Track Status 52 Metricath Gemini 52 coronary stent merged 52 renal denervation 52 pouchitis 52 dalbavancin 52 QUADRAMET R 52 Medtronic CoreValve System 52 E2F Decoy 52 chronic GVHD 52 allogeneic stem cell 52 MPS VI 52 MabThera Rituxan 52 Zeneus 52 patients undergoing percutaneous 52 EndoFLIP ® 52 IMiDs 52 intranasal formulation 52 PGL# 52 AFRS TM 52 IBS C 52 Entereg TM 52 Omigard TM 52 ISO Vorin TM 52 Clolar 52 Gemzar ® 52 eprodisate KIACTA TM 52 Berinert 52 Nivestim 52 carotid artery stent 52 Proxinium TM 52 aerosolized AAT